Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Creative Medical Technology Holdings Inc (CELZ)

Creative Medical Technology Holdings Inc (CELZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Creative Medical Technology Skyrockets on Word of New Diabetes Medication

Creative Medical Technology Holdings, Inc., (NASDAQ:CELZ) shares nearly doubled in price Thursday. The ...

CELZ : 3.25 (unch)
Creative Medical Technology Announces $2 Million Share Repurchase Program

/PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on...

CELZ : 3.25 (unch)
Creative Medical Technology Holdings Provides Corporate Update

/PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on...

CELZ : 3.25 (unch)
Creative Medical Technology Holdings Announces Reverse Stock Split

/PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on...

CELZ : 3.25 (unch)
Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development

/PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on...

CELZ : 3.25 (unch)
Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study

/PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading biotechnology company...

CELZ : 3.25 (unch)
Creative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201

Creative Medical Technology Holdings, Inc. ("Creative Medical Technology Holdings" or the "Company") (NASDAQ: CELZ), a biotechnology company working to revolutionize care through the development of potentially...

CELZ : 3.25 (unch)
SYNH : 42.98 (+0.02%)
Three Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse Effects

Creative Medical Technology Holdings, Inc. ("Creative Medical Technology Holdings" or the "Company") (NASDAQ: CELZ), a biotechnology company working to revolutionize care through the development of potentially...

CELZ : 3.25 (unch)
Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes

/PRNewswire/ -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company working to revolutionize care through the development of...

CELZ : 3.25 (unch)
Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStemâ„¢, a Novel Cell Therapy for the Treatment of Type 1 Diabetes

/PRNewswire/ -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), an immuno-endocrine company working to revolutionize care through the development of...

CELZ : 3.25 (unch)

Barchart Exclusives

GeneDx - AI Healthcare Leader
Summary GeneDx Holdings Corp. offers AI-driven genomics-related diagnostic services, focusing on pediatrics, rare diseases, and hereditary cancer screening, with significant recent price appreciation. Barchart's technical indicators show 100% buy signals, a 919.55% gain in the last year, and strong momentum above key moving averages. Fundamental factors include a $970 million... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar